Search Within

Pedram Razavi

Formats
  1. Meeting Abstract (85)
  2. Journal Article (83)
  3. Editorial (2)
  4. Research Letter (2)
  5. Review (2)
  6. Guidelines (1)
Groups
  1. Breast Medicine Service (175)
  2. Department of Medicine (175)
  3. Solid Tumor Oncology Division (175)
  4. Weinberg Fellows (175)
  5. GSK Faculty (152)
  6. Human Oncology and Pathogenesis Program (124)

More Groups

People
  1. Sarat Chandarlapaty (75)
  2. Jorge Reis-Filho (66)
  3. Michael Berger (45)
  4. Bob Li (41)
  5. David Solit (37)
  6. Dara Ross (32)

More People

Years
  1. 2025 (9)
  2. 2024 (24)
  3. 2023 (11)
  4. 2022 (25)
  5. 2021 (15)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Cancer Research (26)
  3. Modern Pathology (9)
  4. Annals of Oncology (8)
  5. Cancer Discovery (7)
  6. International Journal of Radiation Oncology, Biology, Physics (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. American Association for Cancer Research (40)
  3. Nature Publishing Group (28)
  4. Elsevier Inc. (12)
  5. Cell Press (11)
  6. Nature Research (11)

More Publishers

Results (175)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ARID1A is a critical regulator of luminal identity and therapeutic response in estrogen receptor-positive breast cancer
    Meeting Abstract

    Toska, E.; Xu, G.; Chhangawala, S.; Cocco, E.; Razavi, P.; Otto, J.; Cai, Y.; Chan, C.; D'Avino, D. R.; Collings, C.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Genomic profiling of metastatic breast cancer identifies the Hippo pathway to be a key determinant of CDK4/6 inhibitor sensitivity
    Meeting Abstract

    Razavi, P.; Li, Q.; Li, Z.; Brown, D. N.; Ping, C.; Shen, R.; Sanchez-Vega, F.; Schultz, N. D.; Baselga, J.; Scaltriti, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation
    Meeting Abstract

    Cocco, E.; Kulick, A.; Misale, S.; Yaeger, R.; Razavi, P.; Won, H. H.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; Cownie, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis enhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Toska, E.; Xu, G.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • CDK6 overexpression promotes resistance to CDK4/6 inhibitors in breast cancer
    Meeting Abstract

    Li, Q.; Razavi, P.; Li, Z.; Da Cruz Paula, A. F.; Brogi, E.; Scaltriti, M.; Reis, J. S.; Chandarlapaty, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAPK pathway activation
    Research Letter

    Cocco, E.; Schram, A. M.; Kulick, A.; Misale, S.; Won, H. H.; Yaeger, R.; Razavi, P.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers
    Journal Article

    Osmanbeyoglu, H. U.; Shimizu, F.; Rynne-Vidal, A.; Alonso-Curbelo, D.; Chen, H. A.; Wen, H. Y.; Yeung, T. L.; Jelinic, P.; Razavi, P.; Lowe, S. W.; more...
    Nature Communications (2019)

    Fulltext@MSK | Save
  • Phylogenetic relationship between locoregional recurrences and distant metastasis in breast cancer
    Meeting Abstract

    Billena, C.; Brown, D.; Selenica, P.; Braunstein, L. Z.; Reis-Filho, J.; Powell, S. N.; Razavi, P.; Khan, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Breast cancer in patients age <= 35 years: Overall survival, disease-free survival, secondary malignancies, and contralateral breast cancers rates across 10 years of follow-up
    Meeting Abstract

    Khan, A. J.; Billena, C.; Wilgucki, M.; Flynn, J.; Modlin, L. A.; Tadros, A. B.; Razavi, P.; Braunstein, L. Z.; Gillespie, E. F.; Cahlon, O.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Genetic testing in ultra-young breast cancer patients: A single institution analysis of breast cancer patients <= 35 years at diagnosis
    Meeting Abstract

    Modlin, L. A.; Billena, C.; Wilgucki, M.; Braunstein, L. Z.; Cahlon, O.; McCormick, B.; Tadros, A. B.; Razavi, P.; Morrow, M.; Cody, H. S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save